Track the Biotron Limited share price and the full management transaction log of the company, a publicly traded company based in Australia. Shares are quoted on the AU market, under the supervision of ASX. Operating in the Health Care sector, Biotron Limited has recorded 2 insider filings. Market capitalisation: €5.6m. The latest transaction was reported on 18 August 2026 (Change in Substantial Holding). Among the most active insiders: There was a change in the interests of the. The full history is openly available.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Biotron Limited es una empresa biofarmacéutica australiana centrada en el desarrollo de tratamientos para enfermedades virales y trastornos inmunitarios. Cotiza en la Bolsa de Valores de Australia (XASX).